To amend the Federal Food, Drug, and Cosmetic Act to protect and strengthen the drug supply chain in the United States by closing several statutory gaps in the penalty provisions of such Act that apply to drug diversion and counterfeiting.
USA115th CongressHR-2376| House
| Updated: 5/5/2017
Leonard Lance
Republican Representative
New Jersey
Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Drug Diversion and Counterfeit Crackdown Act of 2017 This bill makes it illegal except in cases of a drug shortage to import into the United States prescription drugs manufactured outside the United States and intended by the manufacturer or labeled to be marketed outside the United States. The bill establishes a penalty for knowingly dispensing or selling a counterfeit drug.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Health
Consumer affairsDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesFraud offenses and financial crimesManufacturing
To amend the Federal Food, Drug, and Cosmetic Act to protect and strengthen the drug supply chain in the United States by closing several statutory gaps in the penalty provisions of such Act that apply to drug diversion and counterfeiting.
USA115th CongressHR-2376| House
| Updated: 5/5/2017
Drug Diversion and Counterfeit Crackdown Act of 2017 This bill makes it illegal except in cases of a drug shortage to import into the United States prescription drugs manufactured outside the United States and intended by the manufacturer or labeled to be marketed outside the United States. The bill establishes a penalty for knowingly dispensing or selling a counterfeit drug.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Leonard Lance
Republican Representative
New Jersey
Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Consumer affairsDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesFraud offenses and financial crimesManufacturing